- Home
- Equipment
- switzerland
- monoclonal or polyclonal antibodies
Show results for
Refine by
Monoclonal Or Polyclonal Antibodies Equipment Supplied In Switzerland
13 equipment items found
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Clone OTI4C5, Anti-DDK (FLAG) monoclonal ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Clone OTI4C5, Anti-DDK (FLAG) monoclonal ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Clone OTI4C5, Anti-DDK (FLAG) Monoclonal antibody, ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Clone OTI4C5, Anti-DDK (FLAG) monoclonal ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Clone OTI4C5, Anti-DDK (FLAG) monoclonal antibody, ...
Manufactured by:Abologix based inGeneva, SWITZERLAND
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific monoclonal antibodies is therefore a logical scientific approach in order to develop new generation inhibitors of angiogenesis. Abologix has produced several recombinant ...
Manufactured by:mAbxience based inMadrid, SPAIN
Fully invested platform of facilities across entire value chain, employing leading single-use bioreactor manufacturing ...
Manufactured by:CELONIC Group based inBasel, SWITZERLAND
An extremely productive and stable CHO-based expression system for biopharmaceuticals. CHOvolution® is a CHO-K1 based expression platform that can be used for a broad range of applications, from non-GMP R&D testing to GMP development and commercial market supply, with a support system to help throughout every step of development. Besides offering cell line development services, Celonic is ...
by:F. Hoffmann-La Roche Ltd. based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
Manufactured by:Prima Lab SA based inBalerna, SWITZERLAND
Helicobacter pylori is a bacterium whose ideal habitat is the human gastric mucosa. The infection is often asymptomatic, but it can sometimes cause gastritis and ulcers in the stomach or in the duodenum segment of the small intestine. The most common symptoms of these conditions are heartburn or pain in the upper part of the abdomen, especially if fasting or in the early morning, when the stomach ...
Manufactured by:Elthera AG based inSchlieren, SWITZERLAND
L1 cell adhesion molecule (L1CAM) is a cell surface protein which is aberrantly expressed in many different tumor types including pancreatic, ovarian, breast, lung, and colorectal cancer. L1CAM expression increases the malignancy of these tumors by promoting cellular proliferation, metastatic spread, tumor angiogenesis, and resistance to chemotherapy. Accordingly, L1CAM-positive tumors ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream ...
